大颗粒淋巴细胞白血病中的克隆性造血
该回顾性研究分析了349例大颗粒淋巴细胞白血病/意义不明的T细胞克隆病患者、672例髓系肿瘤患者和1443例克隆性造血个体,发现8%的LGLL/TCUS病例与髓系肿瘤重叠,另有19%存在克隆性造血,以TET2和DNMT3A突变最常见;LGLL中克隆性造血发生率显著高于年龄匹配的对照,且为血细胞减少的独立危险因素并增加向髓系肿瘤进展风险。
要点
- LGLL/TCUS中克隆性造血发生率为19%,显著高于年龄匹配对照(P<0.0001)。
- 克隆性造血是LGLL患者血细胞减少的独立危险因素(P=0.026)。
- 克隆性造血阳性LGLL患者5年进展至髓系肿瘤率为10%,阴性者为2%(P=0.02)。
核心结论
- 克隆性造血与LGLL密切相关,LGLL中的血细胞减少可能不仅与LGLL相关,也可能继发于共存的克隆性血细胞减少。
研究设计与样本
- 回顾性分析349例LGLL/TCUS患者、672例髓系肿瘤患者和1443例克隆性造血个体。
主要发现
- 8%的LGLL/TCUS病例与髓系肿瘤重叠,另有19%的病例存在克隆性造血(CH+/LGLL),其中TET2突变占23%、DNMT3A突变占14%。
- 髓系肿瘤队列中3%的病例共存LGLL。
- LGLL中克隆性造血发生率显著高于年龄匹配的克隆性造血对照(P<0.0001)。
- 多因素分析显示,LGLL中存在克隆性造血(P=0.026)是血细胞减少的独立危险因素,此外高龄(P=0.003)、脾肿大(P=0.015)和STAT3/5B突变(P=0.001)也是独立危险因素。
- CH+/LGLL病例向髓系肿瘤的进展率高于CH-/LGLL(5年时10% vs. 2%;P=0.02)。
关键数值与推荐
- LGLL/TCUS中克隆性造血发生率为19%,髓系肿瘤重叠率为8%。
- CH+/LGLL中最常见突变为TET2(23%)和DNMT3A(14%)。
- 髓系肿瘤中LGLL共存率为3%。
- CH+/LGLL与CH-/LGLL的5年进展至髓系肿瘤率分别为10%和2%(P=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Past studies described occasional patients with myeloid neoplasms (MN) and coexistent large granular lymphocytic leukemia (LGLL) or T-cell clonopathy of unknown significance (TCUS), which may represent expansion of myeloid clonal hematopoiesis (CH) as triggers or targets of clonal cytotoxic T cell reactions. We retrospectively analyzed 349 LGLL/TCUS patients, 672 MN patients, and 1443 CH individuals to establish the incidence, genetic landscape, and clinical phenotypes of CH in LGLL. We identified 8% of cases overlapping with MN, while CH was found in an additional 19% of cases (CH + /LGLL) of which TET2 (23%) and DNMT3A (14%) were the most common. In MN cohort, 3% of cases showed coexistent LGLL. The incidence of CH in LGLL was exceedingly higher than age-matched CH controls (P < 0.0001). By multivariate analysis, the presence of CH in LGLL (P = 0.026) was an independent risk factor for cytopenia in addition to older age (P = 0.003), splenomegaly (P = 0.015) and STAT3/5B mutations (P = 0.001). CH + /LGLL cases also showed a higher progression rate to MN than CH-/LGLL (10% vs. 2% at 5 years; P = 0.02). A close relationship between CH and LGLL suggests that cytopenia in LGLL may be not only related to LGLL but be also secondary to coexisting clonal cytopenia of unclear significance.
引用
- Kawashima N, Gurnari C, Bravo-Perez C, et al. Clonal hematopoiesis in large granular lymphocytic leukemia. Leukemia. 2024. PMID: 39572711. doi:10.1038/s41375-024-02460-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。